Published in Eur J Clin Microbiol Infect Dis on January 01, 1992
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. Antimicrob Agents Chemother (1993) 1.13
Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents. Drugs (1993) 0.76
Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol (2001) 3.12
Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J Clin Microbiol (1999) 2.23
Should the 'bleach microscopy method' be recommended for improved case detection of tuberculosis? Literature review and key person analysis. Int J Tuberc Lung Dis (2004) 1.93
Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother (1988) 1.76
AIDS and Mycobacterium avium serovars in Sweden. Lancet (1989) 1.55
Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007. Int J Tuberc Lung Dis (2009) 1.52
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur J Clin Microbiol Infect Dis (2001) 1.45
Tenosynovitis of the hand caused by Mycobacterium terrae. Eur J Clin Microbiol Infect Dis (1989) 1.35
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data. J Antimicrob Chemother (2010) 1.34
Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis (1994) 1.33
Improved sputum microscopy for a more sensitive diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 1.33
Molecular epidemiological studies of Mycobacterium bovis infections in humans and animals in Sweden. J Clin Microbiol (1995) 1.33
Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs. Int J Tuberc Lung Dis (1998) 1.22
Establishment of 2-docosanol as a cellular marker compound in the identification of Mycobacterium xenopi. J Clin Microbiol (1989) 1.13
Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis. Clin Microbiol Infect (2003) 1.10
DNA fingerprinting of Mycobacterium tuberculosis strains from patients with pulmonary tuberculosis in Honduras. J Clin Microbiol (1997) 1.10
Mycobacterium kansasii infection in an endemic area of Czechoslovakia. Tubercle (1980) 1.08
Use of IS6110 DNA fingerprinting in tracing man-to-man transmission of Mycobacterium tuberculosis in the Czech Republic. Cent Eur J Public Health (1996) 1.05
New pyridine derivatives as potential antimicrobial agents. Farmaco (1999) 1.05
Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tuber Lung Dis (1993) 1.03
Adverse reactions to BCG. Cent Eur J Public Health (1995) 1.02
A multidrug-resistant tuberculosis microepidemic caused by genetically closely related Mycobacterium tuberculosis strains. J Clin Microbiol (1999) 1.02
Ethambutol: a key for Mycobacterium avium complex chemotherapy? Am Rev Respir Dis (1989) 1.01
Water as a possible factor of transmission in mycobacterial infections. Cent Eur J Public Health (1994) 1.01
Serological typing of mycobacteria for tracing possible sources of avian mycobacterial infections in man. Bull World Health Organ (1968) 0.96
Endemic occurrence of Mycobacterium kansasii in water-supply systems. J Hyg Epidemiol Microbiol Immunol (1981) 0.95
Tuberculosis as an occupational hazard for health care workers in Estonia. Int J Tuberc Lung Dis (2001) 0.95
Does vaccination with bacille Calmette-Guérin protect against AIDS? Rev Infect Dis (1989) 0.92
Antimycobacterial synergism of clarithromycin and rifabutin. Scand J Infect Dis (1996) 0.91
Drug resistant tuberculosis in Estonia. Int J Tuberc Lung Dis (1998) 0.89
Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages. Infect Immun (1992) 0.89
Water-borne household infections due to Mycobacterium xenopi. Cent Eur J Public Health (1993) 0.88
Comparison of Mycobacterium avium complex (MAC) strains from pigs and humans in Sweden by random amplified polymorphic DNA (RAPD) using standardized reagents. Vet Microbiol (2001) 0.87
In vitro studies of cell-mediated immunity in rabbits sensitized with Mycobacterium kansasii and Mycobacterium tuberculosis. Folia Microbiol (Praha) (1980) 0.86
The first occurrence of a multi-drug resistant tuberculosis epidemic in the Czech Republic caused by genetically closely related Mycobacterium tuberculosis strains. Cent Eur J Public Health (2000) 0.86
Cellular immunity in patients with tuberculosis caused by Mycobacterium kansasii and Mycobacterium tuberculosis. J Hyg Epidemiol Microbiol Immunol (1979) 0.85
In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J Antimicrob Chemother (2001) 0.85
Mycobacterium brunense n. sp. identified as serotype Davis of group. 3. (Runyon) Mycobacteria. Zentralbl Bakteriol Orig (1969) 0.85
DNA fingerprint analysis of drug resistant Mycobacterium tuberculosis strains isolated in the Czech Republic. Cent Eur J Public Health (1994) 0.84
[Endemic occurrence of diseases caused by Mycobacterium kansasii in the Karviná industrial agglomeration]. Cas Lek Cesk (1979) 0.82
Antimicrobial susceptibility of Mycobacterium marinum determined by E-test and agar dilution. Scand J Infect Dis (2001) 0.82
Mycobacterium fortuitum complex in Sweden during an 11-year period. Scand J Infect Dis (1997) 0.82
Comparison of microscopic positivity in smears from sputa stained according to Ziehl-Neelsen in different modifications. J Hyg Epidemiol Microbiol Immunol (1977) 0.82
Drug-resistant Mycobacterium tuberculosis and atypical mycobacteria isolated from patients with suspected pulmonary tuberculosis in Honduras. Chest (1997) 0.82
Molecular epidemiology of tuberculosis in Prague and South Moravia, Czech Republic: genetic analysis of Mycobacterium tuberculosis isolates by IS6110-RFLP fingerprinting and spoligotyping. Cent Eur J Public Health (2004) 0.81
Mycobacterium interjectum: a new pathogen in humans? Scand J Infect Dis (2000) 0.80
Increased growth of Mycobacterium malmoense in vitro in the presence of isoniazid. Eur J Clin Microbiol Infect Dis (1991) 0.80
Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities. Bioorg Med Chem (2007) 0.80
Endocellular parasitism of Mycobacterium avium in rabbit liver. A morphological study. Exp Pathol (Jena) (1975) 0.79
Relationships between the chemical structure of antimycobacterial substances and their activity against atypical strains. Part 14: 3-Aryl-6,8-dihalogeno-2H-1,3-benzoxazine-2,4(3H)-diones. Arch Pharm (Weinheim) (1998) 0.79
Incidence of M. avium and M. intracellulare in cattle and pigs. J Hyg Epidemiol Microbiol Immunol (1974) 0.79
[Nontuberculous mycobacteria and incidence of mycobacterioses in Prague in 1999-2004]. Epidemiol Mikrobiol Imunol (2006) 0.78
[New groups of potential antitubercular agents: 3-(4-ethoxythiocarbonylphenyl)-2-H-benzoxazin-2,4(3H)-diones and 3-(4-ethoxythiocarbonylphenyl)-4-thioxy-2H-benzoxazin-2(3H)-ones]. Ceska Slov Farm (2003) 0.78
In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis (2002) 0.77
A new group of potential antituberculotics: hydrochlorides of piperidinylalkyl esters of alkoxy-substituted phenylcarbamic acids. Folia Microbiol (Praha) (2004) 0.77
Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids. Folia Microbiol (Praha) (2003) 0.77
[Antimycobacterial effects of pyrrolidinoethylester alkoxysubstituted phenylcarbamic acids]. Ceska Slov Farm (2002) 0.77
Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime. Diagn Microbiol Infect Dis (1997) 0.77
New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones. Eur J Med Chem (2000) 0.77
Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones. Pharmazie (2003) 0.76
The patterns of complex and partially purified mycobacterial antigens in macrophage migration inhibition testing. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.76
In vitro cellular immune response to homologous and heterologous antigens in rabbits sensitized by five species of Mycobacterium and Nocardia asteroides. Infect Immun (1981) 0.75
Are strains of Mycobacterium avium more drug resistant when isolated from human immunodeficiency virus-infected patients? J Infect Dis (1992) 0.75
A study of mycobacteria isolated from cervical lymph glands of African patients in Kenya. Bull World Health Organ (1960) 0.75
The use of bacillary tuberculosis information system central files for special-purpose data search. J Hyg Epidemiol Microbiol Immunol (1986) 0.75
Comparative studies on detergents - chlorhexidinum gluconicum, ditalan wo hc, sodium-laurylsulphate, laurosept, nekal bx - used for homogenization of diagnostic specimens in the microbiological diagnostic of tuberculosis. Z Erkr Atmungsorgane (1981) 0.75
[Effect of cultivation conditions on some lipid components of Mycobacterium kansasii (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1979) 0.75
[The stratified tuberculoma caused by Mycobacterium kansasii with cavitation (author's transl)]. Z Erkr Atmungsorgane (1977) 0.75
Agreement and disagreement between laboratories in species identification of mycobacteria. Zentralbl Bakteriol A (1981) 0.75
[Nontuberculous myobacterial infections in children and adolescents]. Cesk Pediatr (1965) 0.75
Early response of lymphatic system to experimental infection with Mycobacterium kansasii and Mycobacterium scrofulaceum. J Hyg Epidemiol Microbiol Immunol (1982) 0.75
[Epidemiological study of M. kansasii incidence in Karvinà district (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1973) 0.75
Comparison of different methods of fluorochrome staining of mycobacteria. J Hyg Epidemiol Microbiol Immunol (1977) 0.75
Poly (ethyleneglycol methacrylate) as a material for hemodialysis. J Biomed Mater Res (1973) 0.75
Lymphatic tissues of nude mice during early stages of Mycobacterium kansasii infection. Folia Biol (Praha) (1978) 0.75
Localized chemotherapy of Gardner's lymphosarcoma of C3H mice using combinations of carrier-sorbed antifolics and detoxicating tetrahydrofolates. Czech Med (1981) 0.75
The antimicrobial activity of Fleroxacin RO 23-6240, a third generation fluoroquinolone derivative, tested in vitro. J Hyg Epidemiol Microbiol Immunol (1990) 0.75
Characterization of a monoclonal antibody to Mycobacterium kansasii. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 0.75
Fractionation and purification of the antigenic material for immunogenic studies of atypical mycobacteria. Ann Soc Belg Med Trop (1973) 0.75
A monoclonal antibody to Mycobacterium kansasii: preparation and properties. J Hyg Epidemiol Microbiol Immunol (1987) 0.75
Lymph node activation by a factor released from lymphocytes of normal mice in reaction with Mycobacterium kansasii. Folia Biol (Praha) (1979) 0.75
[Information system for bacillary tuberculosis in the Czech Socialist Republic]. Cesk Zdrav (1978) 0.75
Screening of serum antibodies against Mycobacterium tuberculosis by enzyme-linked immunosorbent assay (ELISA) in healthy population. J Hyg Epidemiol Microbiol Immunol (1989) 0.75
Experimental infection with Mycobacterium kansasii in athymic nude mice. Exp Pathol (1984) 0.75
Comparative testing of skin reactions to PPD mycobacterins from Mycobacterium tuberculosis and Mycobacterium scrofulaceum in school-age children. J Hyg Epidemiol Microbiol Immunol (1984) 0.75
New observations concerning the membrane chromatography of cells. J Chromatogr (1973) 0.75
[A computerized information system of bacillary tuberculosis in the Czech Socialist Republic (author's transl)]. Z Erkr Atmungsorgane (1981) 0.75
Cellular immunity in natural and experimental infections caused by Mycobacterium tuberculosis and Mycobacterium kansasii. Czech Med (1980) 0.75
[Endemic occurrence of Mycobacterium kansasii in the Karviná district]. Cesk Epidemiol Mikrobiol Imunol (1972) 0.75
Field assessment of the direct nitrate reductase assay for rapid detection of multidrug-resistant tuberculosis in Honduras. Int J Tuberc Lung Dis (2011) 0.75
Effect of methotrexate sorbed on modified 2-hydroxyethylmethacrylate carriers in mice of C3H strain with a solid Gardner lymphosarcoma. Neoplasma (1977) 0.75
[Tuberculosis following mycobacteriosis. Apropos of 2 cases]. Rev Mal Respir (1984) 0.75
Membrane chromatography of cells on sponge-like poly(2-hydroxyethyl) methacrylate. J Chromatogr (1972) 0.75
Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin. Neoplasma (1978) 0.75
Bacillary tuberculosis information system: automated evaluation of laboratory-born data in the Czech Socialist Republic. J Hyg Epidemiol Microbiol Immunol (1982) 0.75
[A comparison of some lipid components of the Mycobacterium kansasii strains isolated from patients and sources of supply water (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1979) 0.75
Ionizing radiation in the disinfection of water contaminated with potentially pathogenic mycobacteria. J Hyg Epidemiol Microbiol Immunol (1982) 0.75